ANAVEX LIFE SCIENCES CORP. (AVXL) filed an Amendment No. 1 to its Form 10‑Q for the quarter ended December 31, 2025. After a review overseen by a special committee and the Audit Committee, management reassessed disclosure controls and internal control over financial reporting as of that date.
